Wordt geladen...
Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?
Locally advanced non-small cell lung cancer (NSCLC) represents approximately one third of presentations at diagnosis. Most patients are judged non-surgical due to disease extension, and chemo-radiotherapy still represents the standard therapeutic option, with unsatisfactory results in terms of overa...
Bewaard in:
| Gepubliceerd in: | J Thorac Dis |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994493/ https://ncbi.nlm.nih.gov/pubmed/29951297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.12.53 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|